Doubek, Michael

Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies

Puda, A., Milosevic, J. D., Berg, T., Klampfl, T., Harutyunyan, A. S., Gisslinger, B., Rumi, E., Pietra, D., Malcovati, L., Elena, C., et al. (2012) · American Journal of Hematology

Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments

Cited by 105

Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status

Kubesova, B., Pavlova, S., Malcikova, J., Kabathova, J., Radova, L., Tom, N., Tichy, B., Plevova, K., Kantorova, B., Fiedorova, K., et al. (2018) · Leukemia

Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 82

Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

Zanotti, R., Bonifacio, M., Lucchini, G., Sperr, W. R., Scaffidi, L., van Anrooij, B., Oude Elberink, H. N., Rossignol, J., Hermine, O., Gorska, A., et al. (2022) · Leukemia

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 56

Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin

Fuchs, D., Kilbertus, A., Kofler, K., von Bubnoff, N., Shoumariyeh, K., Zanotti, R., Bonadonna, P., Scaffidi, L., Doubek, M., Elberink, H. O., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineHistiocytic Disorders and Treatments

Cited by 30

The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group

Schwarz, J., Penka, M., Indrák, K., Pospís̆ilová, D., Pytlík, R., Dulíc̆ek, P., Doubek, M., Křen, L., Campr, V, & on behalf of the Czech MPD Working Group (2008) · Leukemia

Myeloproliferative Neoplasms: Diagnosis and TreatmentPlatelet Disorders and Treatments

Cited by 5